vs
Side-by-side financial comparison of NACCO INDUSTRIES INC (NC) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
NACCO INDUSTRIES INC is the larger business by last-quarter revenue ($62.8M vs $57.6M, roughly 1.1× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -4.3%).
NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
NC vs PHAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.8M | $57.6M |
| Net Profit | $8.8M | — |
| Gross Margin | 22.8% | 86.7% |
| Operating Margin | 17.5% | — |
| Net Margin | 14.1% | — |
| Revenue YoY | -4.3% | 94.1% |
| Net Profit YoY | 80.0% | 71.6% |
| EPS (diluted) | $1.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $62.8M | — | ||
| Q4 25 | $66.8M | $57.6M | ||
| Q3 25 | $76.6M | $49.5M | ||
| Q2 25 | $68.2M | $39.5M | ||
| Q1 25 | $65.6M | $28.5M | ||
| Q4 24 | $70.4M | $29.7M | ||
| Q3 24 | $61.7M | $16.4M | ||
| Q2 24 | $52.3M | $7.3M |
| Q1 26 | $8.8M | — | ||
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $13.3M | $-30.0M | ||
| Q2 25 | $3.3M | $-75.8M | ||
| Q1 25 | $4.9M | $-94.3M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $15.6M | $-85.6M | ||
| Q2 24 | $6.0M | $-91.4M |
| Q1 26 | 22.8% | — | ||
| Q4 25 | 18.0% | 86.7% | ||
| Q3 25 | 13.0% | 87.5% | ||
| Q2 25 | 10.0% | 87.2% | ||
| Q1 25 | 14.7% | 86.9% | ||
| Q4 24 | 12.0% | 87.1% | ||
| Q3 24 | 11.7% | 85.6% | ||
| Q2 24 | 13.4% | 81.2% |
| Q1 26 | 17.5% | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 8.8% | -30.8% | ||
| Q2 25 | -0.1% | -151.7% | ||
| Q1 25 | 11.7% | -276.5% | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 31.9% | -433.0% | ||
| Q2 24 | 14.1% | -1055.4% |
| Q1 26 | 14.1% | — | ||
| Q4 25 | -5.8% | — | ||
| Q3 25 | 17.3% | -60.5% | ||
| Q2 25 | 4.8% | -191.9% | ||
| Q1 25 | 7.5% | -330.7% | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 25.4% | -523.3% | ||
| Q2 24 | 11.4% | -1248.6% |
| Q1 26 | $1.17 | — | ||
| Q4 25 | $-0.53 | — | ||
| Q3 25 | $1.78 | $-0.41 | ||
| Q2 25 | $0.44 | $-1.05 | ||
| Q1 25 | $0.66 | $-1.31 | ||
| Q4 24 | $0.99 | — | ||
| Q3 24 | $2.14 | $-1.32 | ||
| Q2 24 | $0.81 | $-1.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | — | $-438.2M |
| Total Assets | — | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $49.7M | $130.0M | ||
| Q3 25 | $52.7M | $135.2M | ||
| Q2 25 | $49.4M | $149.6M | ||
| Q1 25 | $61.9M | $212.3M | ||
| Q4 24 | $72.8M | $297.3M | ||
| Q3 24 | $63.1M | $334.7M | ||
| Q2 24 | $62.4M | $276.2M |
| Q1 26 | — | — | ||
| Q4 25 | $100.8M | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | $99.4M | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | $29.0M | $174.4M |
| Q1 26 | — | — | ||
| Q4 25 | $429.2M | $-438.2M | ||
| Q3 25 | $426.4M | $-422.5M | ||
| Q2 25 | $413.1M | $-405.8M | ||
| Q1 25 | $409.1M | $-338.4M | ||
| Q4 24 | $404.9M | $-253.6M | ||
| Q3 24 | $397.3M | $-187.1M | ||
| Q2 24 | $384.1M | $-233.8M |
| Q1 26 | — | — | ||
| Q4 25 | $661.2M | $259.1M | ||
| Q3 25 | $637.6M | $240.3M | ||
| Q2 25 | $631.3M | $250.2M | ||
| Q1 25 | $634.2M | $294.2M | ||
| Q4 24 | $631.7M | $378.3M | ||
| Q3 24 | $597.4M | $387.0M | ||
| Q2 24 | $560.1M | $319.4M |
| Q1 26 | — | — | ||
| Q4 25 | 0.23× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.08× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-166.8M |
| Free Cash FlowOCF − Capex | — | $-167.0M |
| FCF MarginFCF / Revenue | — | -290.0% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.4M | $-166.8M | ||
| Q3 25 | $42.3M | $-14.1M | ||
| Q2 25 | $-7.8M | $-62.7M | ||
| Q1 25 | $5.0M | $-84.9M | ||
| Q4 24 | $25.2M | $-266.8M | ||
| Q3 24 | $2.8M | $-63.6M | ||
| Q2 24 | $4.1M | $-70.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-167.0M | ||
| Q3 25 | — | $-14.1M | ||
| Q2 25 | — | $-62.8M | ||
| Q1 25 | — | $-84.9M | ||
| Q4 24 | — | $-266.9M | ||
| Q3 24 | — | $-63.6M | ||
| Q2 24 | — | $-70.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -290.0% | ||
| Q3 25 | — | -28.6% | ||
| Q2 25 | — | -159.0% | ||
| Q1 25 | — | -297.9% | ||
| Q4 24 | — | -899.8% | ||
| Q3 24 | — | -389.0% | ||
| Q2 24 | — | -966.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.19× | — | ||
| Q2 25 | -2.39× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 3.33× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
